Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22915643 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Conditions: Hematologic Diseases;   Anemia, Sickle Cell
Interventions: Drug: Hydroxyurea;   Drug: Placebo

Indicates status has not been verified in more than two years